* Results showed partial response being confirmed in 7 out of 42 patients * Partial response was...
* Positive primary endpoint result of objective response rate (ORR) from the planned interim anal...
SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEO: Pae, Jisoo), a global leadi...
SEOUL, South Korea, March 3, 2022 /PRNewswire/ -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jiso...
* Genome and Company expands collaboration with Merck KGaA, Darmstadt, Germany and Pfizer for fur...
SEOUL, South Korea, Feb. 24, 2021 /PRNewswire/ -- Genome & Company (314130, CEO: Jisoo Pae, Hansoo P...
* The first microbiome oncology therapeutic candidate developed by an Asia -based biotech successf...